A Zepbound weight loss chart shows weekly doses and average monthly results. See a sample dosing table, typical progress, and what to ask your doctor.
A Zepbound weight loss chart is a record that pairs weekly tirzepatide doses with weight changes over time. It helps patients and clinicians see typical progress patterns, not a guarantee of individual results. Zepbound is FDA-approved for chronic weight management in adults with obesity or overweight plus at least one weight-related condition.
Charts are most useful when they show both dose and time, because Zepbound is started low and increased slowly. Average results from clinical trials can provide a realistic frame, but your own chart will depend on diet, activity, genetics, and how long you stay on treatment.
What a Zepbound weight loss chart tracks
Most charts include a few core columns: week number, weekly dose in milligrams, weight, and percent change from baseline. Some also track BMI, waist circumference, side effects, and hunger levels.
- Dose: Zepbound is measured in milligrams (mg), not units.
- Time: Weekly entries often roll up into a monthly view.
- Weight: Morning weights before eating tend to be more consistent.
- Context: Sleep, stress, and hydration can affect short-term numbers.
When people search for a zepbound weight loss chart by month, they usually want to know what the first 3, 6, or 12 months look like. Monthly averages smooth out daily fluctuations, which makes trends easier to see.
Zepbound dosing schedule at a glance
Zepbound is given as a once-weekly injection. The standard approach is to start at 2.5 mg for 4 weeks, then move to 5 mg for 4 weeks, and increase by 2.5 mg every 4 weeks if needed and tolerated. The maximum dose is 15 mg weekly.
| Typical weeks | Weekly dose | What it is for |
|---|---|---|
| 1–4 | 2.5 mg | Starting dose; not intended for weight loss |
| 5–8 | 5 mg | First potential maintenance dose |
| 9–12 | 7.5 mg | Step-up dose if tolerated |
| 13–16 | 10 mg | Step-up dose if tolerated |
| 17–20 | 12.5 mg | Step-up dose if tolerated |
| 21+ | 15 mg | Maximum approved weekly dose |
Not everyone needs to reach 15 mg. Some people lose weight steadily at 5 mg or 10 mg and stay there. A chart should reflect your actual prescription, not a forced march to the maximum.
Average weight loss results from clinical trials
In the SURMOUNT-1 trial, adults without diabetes who took tirzepatide for 72 weeks lost an average of about 15% of body weight on 5 mg, 19.5% on 10 mg, and 20.9% on 15 mg. These are averages, and some participants lost more while others lost less.
| Zepbound dose | Average weight loss at 72 weeks | Approximate pounds lost* |
|---|---|---|
| 5 mg weekly | About 15% | About 30–35 lb |
| 10 mg weekly | About 19.5% | About 40–45 lb |
| 15 mg weekly | About 20.9% | About 42–48 lb |
*Approximate ranges assume a starting weight of 200–230 lb. Your results may differ.
Weight loss often slows after 12 to 18 months. A plateau on a chart is common and does not necessarily mean the medication stopped working.
Zepbound weight loss chart PDF and Reddit charts
A zepbound weight loss chart pdf is often a one-page summary from a clinic, manufacturer, or patient community. These PDFs can be useful for logging doses and weights, but they usually show average or example data rather than a personalized prediction.
On a zepbound weight loss chart reddit thread, you will find personal charts with dramatic drops, slow losses, and long plateaus. These stories can be motivating, but they are anecdotal. Reddit charts are not clinical evidence and may come from people using different doses, diets, or compounded products.
How to read your own chart without overreacting
Short-term weight changes are noisy. Sodium intake, menstrual cycles, constipation, and even a hard workout can shift the number on the scale by several pounds.
- Look at 4-week trends instead of daily or weekly swings.
- Track dose changes alongside weight so you can see cause and effect.
- Note side effects, because they may affect how long you stay at a dose.
- Take measurements and photos if the scale stalls but clothes fit differently.
If you are comparing medication options, a tirzepatide dosage chart for weight loss is relevant because Zepbound is tirzepatide. Some patients also look at an ozempic for weight loss dosage chart, but Ozempic contains semaglutide and is approved for diabetes, not weight loss. People using compounded semaglutide sometimes follow a semaglutide weight loss dosage chart in units, which does not match Zepbound's milligram-based pens.
BPC-157 is a different compound entirely. It is not FDA-approved for human use in the United States, and a bpc-157 dosage chart by weight is not a substitute for an obesity treatment plan. For anyone asking does bpc-157 help with weight loss, the current evidence is limited and does not support it as a proven weight-loss drug.
Safety, side effects, and when to call a doctor
Common Zepbound side effects include nausea, diarrhea, vomiting, constipation, and stomach pain. Most are mild to moderate and improve as the body adjusts, but they can be severe.
Zepbound carries a boxed warning for thyroid C-cell tumors, and it should not be used by people with a personal or family history of medullary thyroid cancer or MEN2. Pancreatitis and gallbladder problems have also been reported.
Contact a healthcare professional if you have severe abdominal pain, persistent vomiting, signs of dehydration, or symptoms of pancreatitis. Do not start, stop, or change doses without medical guidance.
Questions to ask your prescriber
- What dose am I starting, and when should it increase?
- What weight-loss range is realistic for me at 3, 6, and 12 months?
- Which side effects should make me call your office right away?
- How should I track my progress between visits?
The bottom line
A Zepbound weight loss chart is a tracking tool, not a promise. It becomes most useful when it combines your actual dose, your weekly weights, and your side effects. Average trial results can set expectations, but your own trend line is the one that matters.
Always discuss weight-loss goals and medication risks with a licensed healthcare professional. Zepbound is a prescription drug, and individual results vary.
Frequently Asked Questions
How much weight can I lose on Zepbound in 3 months?
In clinical trials, average weight loss at 3 months was modest, often around 5% of body weight, because the dose is still being increased. The largest losses typically appear after 6 to 12 months at a stable maintenance dose. Your results will depend on your starting weight, dose, and lifestyle.
Is there an official Zepbound weight loss chart PDF?
Eli Lilly does not publish a single official weight-loss chart for every patient. Clinics and patient communities often create their own PDF trackers that include dose, date, weight, and side effects. You can also ask your prescriber for a tracking sheet that matches your prescription.
Why does my Zepbound weight loss chart show a plateau?
Plateaus are common and can happen because of water retention, dose adjustments, or metabolic adaptation. A true plateau is usually defined as no weight loss for 4 to 8 weeks despite consistent dosing and lifestyle habits. Talk with your prescriber before changing your dose or stopping treatment.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.